nodes	percent_of_prediction	percent_of_DWPC	metapath
Ropivacaine—CYP2B6—Thiotepa—sarcoma	0.244	0.412	CbGbCtD
Ropivacaine—CYP1A2—Dacarbazine—sarcoma	0.0792	0.134	CbGbCtD
Ropivacaine—CYP3A4—Thiotepa—sarcoma	0.0748	0.126	CbGbCtD
Ropivacaine—CYP2B6—Doxorubicin—sarcoma	0.0451	0.0761	CbGbCtD
Ropivacaine—CYP1A2—Etoposide—sarcoma	0.0387	0.0655	CbGbCtD
Ropivacaine—CYP3A4—Mitoxantrone—sarcoma	0.0322	0.0544	CbGbCtD
Ropivacaine—CYP3A4—Vincristine—sarcoma	0.0221	0.0374	CbGbCtD
Ropivacaine—CYP2D6—Doxorubicin—sarcoma	0.0218	0.0368	CbGbCtD
Ropivacaine—CYP3A4—Etoposide—sarcoma	0.0203	0.0343	CbGbCtD
Ropivacaine—CYP3A4—Doxorubicin—sarcoma	0.0138	0.0234	CbGbCtD
Ropivacaine—Lidocaine—EGFR—sarcoma	0.00214	1	CrCbGaD
Ropivacaine—Body temperature increased—Thiotepa—sarcoma	0.00042	0.00123	CcSEcCtD
Ropivacaine—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000418	0.00122	CcSEcCtD
Ropivacaine—Purpura—Doxorubicin—sarcoma	0.000418	0.00122	CcSEcCtD
Ropivacaine—Abdominal pain—Dactinomycin—sarcoma	0.000417	0.00122	CcSEcCtD
Ropivacaine—Body temperature increased—Dactinomycin—sarcoma	0.000417	0.00122	CcSEcCtD
Ropivacaine—Anaphylactoid reaction—Doxorubicin—sarcoma	0.000416	0.00122	CcSEcCtD
Ropivacaine—Cardiac arrest—Epirubicin—sarcoma	0.000414	0.00121	CcSEcCtD
Ropivacaine—Hypoglycaemia—Doxorubicin—sarcoma	0.000413	0.00121	CcSEcCtD
Ropivacaine—Mood swings—Epirubicin—sarcoma	0.000413	0.00121	CcSEcCtD
Ropivacaine—Paraesthesia—Mitoxantrone—sarcoma	0.000412	0.00121	CcSEcCtD
Ropivacaine—Loss of consciousness—Etoposide—sarcoma	0.000411	0.0012	CcSEcCtD
Ropivacaine—Dyspnoea—Mitoxantrone—sarcoma	0.000409	0.0012	CcSEcCtD
Ropivacaine—Cough—Etoposide—sarcoma	0.000408	0.00119	CcSEcCtD
Ropivacaine—Somnolence—Mitoxantrone—sarcoma	0.000408	0.00119	CcSEcCtD
Ropivacaine—Convulsion—Etoposide—sarcoma	0.000405	0.00119	CcSEcCtD
Ropivacaine—Dyspepsia—Mitoxantrone—sarcoma	0.000404	0.00118	CcSEcCtD
Ropivacaine—Hypertension—Etoposide—sarcoma	0.000404	0.00118	CcSEcCtD
Ropivacaine—Pain—Vincristine—sarcoma	0.000403	0.00118	CcSEcCtD
Ropivacaine—Constipation—Vincristine—sarcoma	0.000403	0.00118	CcSEcCtD
Ropivacaine—Osteoarthritis—Doxorubicin—sarcoma	0.000403	0.00118	CcSEcCtD
Ropivacaine—Chest pain—Etoposide—sarcoma	0.000398	0.00117	CcSEcCtD
Ropivacaine—Orthostatic hypotension—Epirubicin—sarcoma	0.000398	0.00116	CcSEcCtD
Ropivacaine—Affect lability—Doxorubicin—sarcoma	0.000397	0.00116	CcSEcCtD
Ropivacaine—Hypokalaemia—Epirubicin—sarcoma	0.000396	0.00116	CcSEcCtD
Ropivacaine—Discomfort—Etoposide—sarcoma	0.000394	0.00115	CcSEcCtD
Ropivacaine—Breast disorder—Epirubicin—sarcoma	0.000394	0.00115	CcSEcCtD
Ropivacaine—Pain—Mitoxantrone—sarcoma	0.000393	0.00115	CcSEcCtD
Ropivacaine—Constipation—Mitoxantrone—sarcoma	0.000393	0.00115	CcSEcCtD
Ropivacaine—SCN1A—Developmental Biology—EZR—sarcoma	0.000392	0.0061	CbGpPWpGaD
Ropivacaine—Aspartate aminotransferase increased—Epirubicin—sarcoma	0.000392	0.00115	CcSEcCtD
Ropivacaine—Hypersensitivity—Thiotepa—sarcoma	0.000392	0.00115	CcSEcCtD
Ropivacaine—SCN8A—L1CAM interactions—SRC—sarcoma	0.000389	0.00605	CbGpPWpGaD
Ropivacaine—Hypersensitivity—Dactinomycin—sarcoma	0.000389	0.00114	CcSEcCtD
Ropivacaine—SCN5A—Axon guidance—EZR—sarcoma	0.000387	0.00601	CbGpPWpGaD
Ropivacaine—Gastrointestinal pain—Vincristine—sarcoma	0.000385	0.00113	CcSEcCtD
Ropivacaine—Confusional state—Etoposide—sarcoma	0.000385	0.00113	CcSEcCtD
Ropivacaine—Alanine aminotransferase increased—Epirubicin—sarcoma	0.000384	0.00112	CcSEcCtD
Ropivacaine—Cardiac arrest—Doxorubicin—sarcoma	0.000383	0.00112	CcSEcCtD
Ropivacaine—Anaphylactic shock—Etoposide—sarcoma	0.000382	0.00112	CcSEcCtD
Ropivacaine—Mood swings—Doxorubicin—sarcoma	0.000382	0.00112	CcSEcCtD
Ropivacaine—Asthenia—Thiotepa—sarcoma	0.000381	0.00112	CcSEcCtD
Ropivacaine—Infection—Etoposide—sarcoma	0.000379	0.00111	CcSEcCtD
Ropivacaine—Abdominal distension—Epirubicin—sarcoma	0.000379	0.00111	CcSEcCtD
Ropivacaine—Asthenia—Dactinomycin—sarcoma	0.000379	0.00111	CcSEcCtD
Ropivacaine—Feeling abnormal—Mitoxantrone—sarcoma	0.000378	0.00111	CcSEcCtD
Ropivacaine—Pruritus—Thiotepa—sarcoma	0.000376	0.0011	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000375	0.0011	CcSEcCtD
Ropivacaine—Thrombocytopenia—Etoposide—sarcoma	0.000374	0.00109	CcSEcCtD
Ropivacaine—Tachycardia—Etoposide—sarcoma	0.000373	0.00109	CcSEcCtD
Ropivacaine—Abdominal pain—Vincristine—sarcoma	0.000373	0.00109	CcSEcCtD
Ropivacaine—Body temperature increased—Vincristine—sarcoma	0.000373	0.00109	CcSEcCtD
Ropivacaine—Skin disorder—Etoposide—sarcoma	0.000371	0.00109	CcSEcCtD
Ropivacaine—Hyperhidrosis—Etoposide—sarcoma	0.000369	0.00108	CcSEcCtD
Ropivacaine—Orthostatic hypotension—Doxorubicin—sarcoma	0.000368	0.00108	CcSEcCtD
Ropivacaine—Hypokalaemia—Doxorubicin—sarcoma	0.000367	0.00107	CcSEcCtD
Ropivacaine—SCN9A—Axon guidance—PTPRC—sarcoma	0.000366	0.00569	CbGpPWpGaD
Ropivacaine—Urticaria—Mitoxantrone—sarcoma	0.000365	0.00107	CcSEcCtD
Ropivacaine—Breast disorder—Doxorubicin—sarcoma	0.000364	0.00107	CcSEcCtD
Ropivacaine—SCN5A—Developmental Biology—MYOG—sarcoma	0.000364	0.00566	CbGpPWpGaD
Ropivacaine—Diarrhoea—Thiotepa—sarcoma	0.000364	0.00106	CcSEcCtD
Ropivacaine—Body temperature increased—Mitoxantrone—sarcoma	0.000363	0.00106	CcSEcCtD
Ropivacaine—Abdominal pain—Mitoxantrone—sarcoma	0.000363	0.00106	CcSEcCtD
Ropivacaine—Aspartate aminotransferase increased—Doxorubicin—sarcoma	0.000363	0.00106	CcSEcCtD
Ropivacaine—Diarrhoea—Dactinomycin—sarcoma	0.000361	0.00106	CcSEcCtD
Ropivacaine—SCN9A—Developmental Biology—MYOD1—sarcoma	0.000361	0.00561	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—PLCG1—sarcoma	0.000358	0.00557	CbGpPWpGaD
Ropivacaine—Hypotension—Etoposide—sarcoma	0.000357	0.00104	CcSEcCtD
Ropivacaine—Alanine aminotransferase increased—Doxorubicin—sarcoma	0.000355	0.00104	CcSEcCtD
Ropivacaine—Dysuria—Epirubicin—sarcoma	0.000352	0.00103	CcSEcCtD
Ropivacaine—Dizziness—Thiotepa—sarcoma	0.000352	0.00103	CcSEcCtD
Ropivacaine—Abdominal distension—Doxorubicin—sarcoma	0.000351	0.00103	CcSEcCtD
Ropivacaine—SCN3A—Axon guidance—PTPRC—sarcoma	0.00035	0.00544	CbGpPWpGaD
Ropivacaine—Hypersensitivity—Vincristine—sarcoma	0.000347	0.00102	CcSEcCtD
Ropivacaine—SCN3A—Developmental Biology—MYOD1—sarcoma	0.000345	0.00537	CbGpPWpGaD
Ropivacaine—Paraesthesia—Etoposide—sarcoma	0.000343	0.001	CcSEcCtD
Ropivacaine—SCN3A—Axon guidance—PLCG1—sarcoma	0.000342	0.00532	CbGpPWpGaD
Ropivacaine—SCN8A—L1CAM interactions—EGFR—sarcoma	0.000341	0.0053	CbGpPWpGaD
Ropivacaine—Dyspnoea—Etoposide—sarcoma	0.00034	0.000996	CcSEcCtD
Ropivacaine—CYP2D6—Melatonin metabolism and effects—FOXO1—sarcoma	0.00034	0.00528	CbGpPWpGaD
Ropivacaine—Hyperglycaemia—Epirubicin—sarcoma	0.00034	0.000993	CcSEcCtD
Ropivacaine—Somnolence—Etoposide—sarcoma	0.000339	0.000993	CcSEcCtD
Ropivacaine—Hypersensitivity—Mitoxantrone—sarcoma	0.000338	0.000989	CcSEcCtD
Ropivacaine—Asthenia—Vincristine—sarcoma	0.000338	0.000989	CcSEcCtD
Ropivacaine—Vomiting—Thiotepa—sarcoma	0.000338	0.000989	CcSEcCtD
Ropivacaine—SCN2A—Axon guidance—PTPRC—sarcoma	0.000336	0.00523	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—PTPRC—sarcoma	0.000336	0.00523	CbGpPWpGaD
Ropivacaine—Drowsiness—Epirubicin—sarcoma	0.000336	0.000982	CcSEcCtD
Ropivacaine—Vomiting—Dactinomycin—sarcoma	0.000335	0.000981	CcSEcCtD
Ropivacaine—Rash—Thiotepa—sarcoma	0.000335	0.000981	CcSEcCtD
Ropivacaine—Dermatitis—Thiotepa—sarcoma	0.000335	0.00098	CcSEcCtD
Ropivacaine—Headache—Thiotepa—sarcoma	0.000333	0.000974	CcSEcCtD
Ropivacaine—Rash—Dactinomycin—sarcoma	0.000333	0.000973	CcSEcCtD
Ropivacaine—SCN4A—Developmental Biology—MYOD1—sarcoma	0.000332	0.00516	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—MYOD1—sarcoma	0.000332	0.00516	CbGpPWpGaD
Ropivacaine—Asthenia—Mitoxantrone—sarcoma	0.000329	0.000964	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Epirubicin—sarcoma	0.000329	0.000962	CcSEcCtD
Ropivacaine—SCN2A—Axon guidance—PLCG1—sarcoma	0.000329	0.00511	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—PLCG1—sarcoma	0.000329	0.00511	CbGpPWpGaD
Ropivacaine—Jaundice—Epirubicin—sarcoma	0.000327	0.000957	CcSEcCtD
Ropivacaine—Constipation—Etoposide—sarcoma	0.000327	0.000955	CcSEcCtD
Ropivacaine—Pain—Etoposide—sarcoma	0.000327	0.000955	CcSEcCtD
Ropivacaine—Urinary tract infection—Epirubicin—sarcoma	0.000326	0.000954	CcSEcCtD
Ropivacaine—Dysuria—Doxorubicin—sarcoma	0.000326	0.000953	CcSEcCtD
Ropivacaine—SCN10A—Axon guidance—PTPRC—sarcoma	0.000324	0.00504	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—PTPRC—sarcoma	0.000324	0.00504	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—PTPRC—sarcoma	0.000323	0.00502	CbGpPWpGaD
Ropivacaine—Diarrhoea—Vincristine—sarcoma	0.000323	0.000944	CcSEcCtD
Ropivacaine—Haematuria—Epirubicin—sarcoma	0.00032	0.000936	CcSEcCtD
Ropivacaine—SCN1A—Developmental Biology—MYOD1—sarcoma	0.00032	0.00497	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—MYOD1—sarcoma	0.00032	0.00497	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—PLCG1—sarcoma	0.000317	0.00493	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—PLCG1—sarcoma	0.000317	0.00493	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—PLCG1—sarcoma	0.000316	0.00491	CbGpPWpGaD
Ropivacaine—Nausea—Thiotepa—sarcoma	0.000316	0.000924	CcSEcCtD
Ropivacaine—Feeling abnormal—Etoposide—sarcoma	0.000315	0.000921	CcSEcCtD
Ropivacaine—SCN9A—L1CAM interactions—SRC—sarcoma	0.000314	0.00489	CbGpPWpGaD
Ropivacaine—Hyperglycaemia—Doxorubicin—sarcoma	0.000314	0.000919	CcSEcCtD
Ropivacaine—Diarrhoea—Mitoxantrone—sarcoma	0.000314	0.000919	CcSEcCtD
Ropivacaine—Nausea—Dactinomycin—sarcoma	0.000313	0.000917	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Etoposide—sarcoma	0.000312	0.000913	CcSEcCtD
Ropivacaine—Dizziness—Vincristine—sarcoma	0.000312	0.000912	CcSEcCtD
Ropivacaine—Drowsiness—Doxorubicin—sarcoma	0.000311	0.000908	CcSEcCtD
Ropivacaine—Bradycardia—Epirubicin—sarcoma	0.000307	0.000897	CcSEcCtD
Ropivacaine—Neuropathy peripheral—Doxorubicin—sarcoma	0.000304	0.000891	CcSEcCtD
Ropivacaine—Urticaria—Etoposide—sarcoma	0.000303	0.000887	CcSEcCtD
Ropivacaine—Jaundice—Doxorubicin—sarcoma	0.000303	0.000886	CcSEcCtD
Ropivacaine—Rhinitis—Epirubicin—sarcoma	0.000302	0.000884	CcSEcCtD
Ropivacaine—Body temperature increased—Etoposide—sarcoma	0.000302	0.000883	CcSEcCtD
Ropivacaine—Abdominal pain—Etoposide—sarcoma	0.000302	0.000883	CcSEcCtD
Ropivacaine—Urinary tract infection—Doxorubicin—sarcoma	0.000302	0.000883	CcSEcCtD
Ropivacaine—SCN3A—L1CAM interactions—SRC—sarcoma	0.000301	0.00468	CbGpPWpGaD
Ropivacaine—Hypoaesthesia—Epirubicin—sarcoma	0.0003	0.000877	CcSEcCtD
Ropivacaine—Vomiting—Vincristine—sarcoma	0.0003	0.000877	CcSEcCtD
Ropivacaine—Urinary tract disorder—Epirubicin—sarcoma	0.000298	0.00087	CcSEcCtD
Ropivacaine—Rash—Vincristine—sarcoma	0.000297	0.00087	CcSEcCtD
Ropivacaine—Dermatitis—Vincristine—sarcoma	0.000297	0.000869	CcSEcCtD
Ropivacaine—Oedema peripheral—Epirubicin—sarcoma	0.000297	0.000868	CcSEcCtD
Ropivacaine—Haematuria—Doxorubicin—sarcoma	0.000296	0.000866	CcSEcCtD
Ropivacaine—Urethral disorder—Epirubicin—sarcoma	0.000295	0.000864	CcSEcCtD
Ropivacaine—Headache—Vincristine—sarcoma	0.000295	0.000864	CcSEcCtD
Ropivacaine—Vomiting—Mitoxantrone—sarcoma	0.000292	0.000854	CcSEcCtD
Ropivacaine—Rash—Mitoxantrone—sarcoma	0.000289	0.000847	CcSEcCtD
Ropivacaine—Dermatitis—Mitoxantrone—sarcoma	0.000289	0.000846	CcSEcCtD
Ropivacaine—SCN4A—L1CAM interactions—SRC—sarcoma	0.000289	0.00449	CbGpPWpGaD
Ropivacaine—SCN2A—L1CAM interactions—SRC—sarcoma	0.000289	0.00449	CbGpPWpGaD
Ropivacaine—CYP1A2—Melatonin metabolism and effects—FOXO1—sarcoma	0.000288	0.00448	CbGpPWpGaD
Ropivacaine—Headache—Mitoxantrone—sarcoma	0.000288	0.000841	CcSEcCtD
Ropivacaine—CYP1A2—Estrogen Receptor Pathway—JUN—sarcoma	0.000285	0.00444	CbGpPWpGaD
Ropivacaine—Bradycardia—Doxorubicin—sarcoma	0.000284	0.00083	CcSEcCtD
Ropivacaine—Hypersensitivity—Etoposide—sarcoma	0.000281	0.000823	CcSEcCtD
Ropivacaine—Tinnitus—Epirubicin—sarcoma	0.000281	0.000822	CcSEcCtD
Ropivacaine—Nausea—Vincristine—sarcoma	0.00028	0.000819	CcSEcCtD
Ropivacaine—Cardiac disorder—Epirubicin—sarcoma	0.00028	0.000818	CcSEcCtD
Ropivacaine—Rhinitis—Doxorubicin—sarcoma	0.000279	0.000818	CcSEcCtD
Ropivacaine—SCN1A—L1CAM interactions—SRC—sarcoma	0.000279	0.00433	CbGpPWpGaD
Ropivacaine—SCN10A—L1CAM interactions—SRC—sarcoma	0.000279	0.00433	CbGpPWpGaD
Ropivacaine—Hypoaesthesia—Doxorubicin—sarcoma	0.000277	0.000811	CcSEcCtD
Ropivacaine—SCN5A—Developmental Biology—EZR—sarcoma	0.000276	0.00429	CbGpPWpGaD
Ropivacaine—SCN9A—L1CAM interactions—EGFR—sarcoma	0.000276	0.00429	CbGpPWpGaD
Ropivacaine—Urinary tract disorder—Doxorubicin—sarcoma	0.000275	0.000805	CcSEcCtD
Ropivacaine—Oedema peripheral—Doxorubicin—sarcoma	0.000275	0.000803	CcSEcCtD
Ropivacaine—Asthenia—Etoposide—sarcoma	0.000274	0.000802	CcSEcCtD
Ropivacaine—Urethral disorder—Doxorubicin—sarcoma	0.000273	0.000799	CcSEcCtD
Ropivacaine—Nausea—Mitoxantrone—sarcoma	0.000273	0.000798	CcSEcCtD
Ropivacaine—Chills—Epirubicin—sarcoma	0.00027	0.000791	CcSEcCtD
Ropivacaine—Pruritus—Etoposide—sarcoma	0.00027	0.00079	CcSEcCtD
Ropivacaine—Arrhythmia—Epirubicin—sarcoma	0.000269	0.000787	CcSEcCtD
Ropivacaine—Mental disorder—Epirubicin—sarcoma	0.000264	0.000772	CcSEcCtD
Ropivacaine—SCN3A—L1CAM interactions—EGFR—sarcoma	0.000264	0.0041	CbGpPWpGaD
Ropivacaine—Erythema—Epirubicin—sarcoma	0.000262	0.000767	CcSEcCtD
Ropivacaine—Diarrhoea—Etoposide—sarcoma	0.000261	0.000764	CcSEcCtD
Ropivacaine—SCN9A—Developmental Biology—PTPRC—sarcoma	0.000261	0.00406	CbGpPWpGaD
Ropivacaine—Tinnitus—Doxorubicin—sarcoma	0.00026	0.00076	CcSEcCtD
Ropivacaine—SCN8A—Axon guidance—KDR—sarcoma	0.00026	0.00404	CbGpPWpGaD
Ropivacaine—Cardiac disorder—Doxorubicin—sarcoma	0.000259	0.000757	CcSEcCtD
Ropivacaine—Tension—Epirubicin—sarcoma	0.000257	0.000753	CcSEcCtD
Ropivacaine—SCN9A—Developmental Biology—PLCG1—sarcoma	0.000255	0.00397	CbGpPWpGaD
Ropivacaine—Nervousness—Epirubicin—sarcoma	0.000255	0.000745	CcSEcCtD
Ropivacaine—Back pain—Epirubicin—sarcoma	0.000254	0.000742	CcSEcCtD
Ropivacaine—SCN4A—L1CAM interactions—EGFR—sarcoma	0.000253	0.00394	CbGpPWpGaD
Ropivacaine—SCN2A—L1CAM interactions—EGFR—sarcoma	0.000253	0.00394	CbGpPWpGaD
Ropivacaine—Dizziness—Etoposide—sarcoma	0.000253	0.000739	CcSEcCtD
Ropivacaine—Muscle spasms—Epirubicin—sarcoma	0.000252	0.000738	CcSEcCtD
Ropivacaine—Chills—Doxorubicin—sarcoma	0.00025	0.000732	CcSEcCtD
Ropivacaine—SCN3A—Developmental Biology—PTPRC—sarcoma	0.00025	0.00388	CbGpPWpGaD
Ropivacaine—Arrhythmia—Doxorubicin—sarcoma	0.000249	0.000729	CcSEcCtD
Ropivacaine—Vision blurred—Epirubicin—sarcoma	0.000247	0.000723	CcSEcCtD
Ropivacaine—SCN3A—Developmental Biology—PLCG1—sarcoma	0.000244	0.0038	CbGpPWpGaD
Ropivacaine—Mental disorder—Doxorubicin—sarcoma	0.000244	0.000714	CcSEcCtD
Ropivacaine—SCN1A—L1CAM interactions—EGFR—sarcoma	0.000244	0.0038	CbGpPWpGaD
Ropivacaine—SCN10A—L1CAM interactions—EGFR—sarcoma	0.000244	0.0038	CbGpPWpGaD
Ropivacaine—Ill-defined disorder—Epirubicin—sarcoma	0.000243	0.000712	CcSEcCtD
Ropivacaine—Vomiting—Etoposide—sarcoma	0.000243	0.00071	CcSEcCtD
Ropivacaine—Erythema—Doxorubicin—sarcoma	0.000243	0.00071	CcSEcCtD
Ropivacaine—Anaemia—Epirubicin—sarcoma	0.000242	0.000709	CcSEcCtD
Ropivacaine—Agitation—Epirubicin—sarcoma	0.000241	0.000705	CcSEcCtD
Ropivacaine—Rash—Etoposide—sarcoma	0.000241	0.000704	CcSEcCtD
Ropivacaine—Dermatitis—Etoposide—sarcoma	0.000241	0.000704	CcSEcCtD
Ropivacaine—SCN2A—Developmental Biology—PTPRC—sarcoma	0.00024	0.00373	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—PTPRC—sarcoma	0.00024	0.00373	CbGpPWpGaD
Ropivacaine—Headache—Etoposide—sarcoma	0.000239	0.0007	CcSEcCtD
Ropivacaine—Tension—Doxorubicin—sarcoma	0.000238	0.000697	CcSEcCtD
Ropivacaine—Malaise—Epirubicin—sarcoma	0.000237	0.000692	CcSEcCtD
Ropivacaine—Nervousness—Doxorubicin—sarcoma	0.000236	0.00069	CcSEcCtD
Ropivacaine—Vertigo—Epirubicin—sarcoma	0.000236	0.000689	CcSEcCtD
Ropivacaine—Syncope—Epirubicin—sarcoma	0.000235	0.000688	CcSEcCtD
Ropivacaine—Back pain—Doxorubicin—sarcoma	0.000235	0.000687	CcSEcCtD
Ropivacaine—SCN2A—Developmental Biology—PLCG1—sarcoma	0.000235	0.00365	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—PLCG1—sarcoma	0.000235	0.00365	CbGpPWpGaD
Ropivacaine—Muscle spasms—Doxorubicin—sarcoma	0.000233	0.000683	CcSEcCtD
Ropivacaine—SCN10A—Developmental Biology—PTPRC—sarcoma	0.000231	0.0036	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—PTPRC—sarcoma	0.000231	0.0036	CbGpPWpGaD
Ropivacaine—Loss of consciousness—Epirubicin—sarcoma	0.000231	0.000674	CcSEcCtD
Ropivacaine—Cough—Epirubicin—sarcoma	0.000229	0.00067	CcSEcCtD
Ropivacaine—Vision blurred—Doxorubicin—sarcoma	0.000229	0.000669	CcSEcCtD
Ropivacaine—SCN5A—Axon guidance—PTPRC—sarcoma	0.000228	0.00354	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—CREB1—sarcoma	0.000228	0.00354	CbGpPWpGaD
Ropivacaine—Convulsion—Epirubicin—sarcoma	0.000227	0.000665	CcSEcCtD
Ropivacaine—Nausea—Etoposide—sarcoma	0.000227	0.000664	CcSEcCtD
Ropivacaine—Hypertension—Epirubicin—sarcoma	0.000226	0.000662	CcSEcCtD
Ropivacaine—SCN10A—Developmental Biology—PLCG1—sarcoma	0.000226	0.00352	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—PLCG1—sarcoma	0.000226	0.00352	CbGpPWpGaD
Ropivacaine—Ill-defined disorder—Doxorubicin—sarcoma	0.000225	0.000659	CcSEcCtD
Ropivacaine—SCN5A—Developmental Biology—MYOD1—sarcoma	0.000225	0.0035	CbGpPWpGaD
Ropivacaine—Anaemia—Doxorubicin—sarcoma	0.000224	0.000656	CcSEcCtD
Ropivacaine—SCN8A—Developmental Biology—FOXO1—sarcoma	0.000224	0.00348	CbGpPWpGaD
Ropivacaine—Chest pain—Epirubicin—sarcoma	0.000223	0.000653	CcSEcCtD
Ropivacaine—Arthralgia—Epirubicin—sarcoma	0.000223	0.000653	CcSEcCtD
Ropivacaine—Myalgia—Epirubicin—sarcoma	0.000223	0.000653	CcSEcCtD
Ropivacaine—Agitation—Doxorubicin—sarcoma	0.000223	0.000652	CcSEcCtD
Ropivacaine—SCN5A—Axon guidance—PLCG1—sarcoma	0.000223	0.00347	CbGpPWpGaD
Ropivacaine—Anxiety—Epirubicin—sarcoma	0.000223	0.000651	CcSEcCtD
Ropivacaine—Discomfort—Epirubicin—sarcoma	0.000221	0.000645	CcSEcCtD
Ropivacaine—Malaise—Doxorubicin—sarcoma	0.000219	0.00064	CcSEcCtD
Ropivacaine—Vertigo—Doxorubicin—sarcoma	0.000218	0.000638	CcSEcCtD
Ropivacaine—Syncope—Doxorubicin—sarcoma	0.000218	0.000637	CcSEcCtD
Ropivacaine—Confusional state—Epirubicin—sarcoma	0.000216	0.000631	CcSEcCtD
Ropivacaine—Anaphylactic shock—Epirubicin—sarcoma	0.000214	0.000626	CcSEcCtD
Ropivacaine—Loss of consciousness—Doxorubicin—sarcoma	0.000213	0.000624	CcSEcCtD
Ropivacaine—Infection—Epirubicin—sarcoma	0.000213	0.000622	CcSEcCtD
Ropivacaine—SCN8A—Axon guidance—MMP2—sarcoma	0.000212	0.0033	CbGpPWpGaD
Ropivacaine—Cough—Doxorubicin—sarcoma	0.000212	0.00062	CcSEcCtD
Ropivacaine—Shock—Epirubicin—sarcoma	0.000211	0.000616	CcSEcCtD
Ropivacaine—Convulsion—Doxorubicin—sarcoma	0.00021	0.000615	CcSEcCtD
Ropivacaine—SCN9A—Axon guidance—KDR—sarcoma	0.00021	0.00327	CbGpPWpGaD
Ropivacaine—Thrombocytopenia—Epirubicin—sarcoma	0.00021	0.000613	CcSEcCtD
Ropivacaine—Hypertension—Doxorubicin—sarcoma	0.00021	0.000613	CcSEcCtD
Ropivacaine—Tachycardia—Epirubicin—sarcoma	0.000209	0.000611	CcSEcCtD
Ropivacaine—Skin disorder—Epirubicin—sarcoma	0.000208	0.000608	CcSEcCtD
Ropivacaine—Hyperhidrosis—Epirubicin—sarcoma	0.000207	0.000605	CcSEcCtD
Ropivacaine—Myalgia—Doxorubicin—sarcoma	0.000207	0.000604	CcSEcCtD
Ropivacaine—Arthralgia—Doxorubicin—sarcoma	0.000207	0.000604	CcSEcCtD
Ropivacaine—Chest pain—Doxorubicin—sarcoma	0.000207	0.000604	CcSEcCtD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—CREB1—sarcoma	0.000206	0.0032	CbGpPWpGaD
Ropivacaine—Anxiety—Doxorubicin—sarcoma	0.000206	0.000602	CcSEcCtD
Ropivacaine—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000205	0.00319	CbGpPWpGaD
Ropivacaine—Discomfort—Doxorubicin—sarcoma	0.000204	0.000597	CcSEcCtD
Ropivacaine—SCN3A—Axon guidance—KDR—sarcoma	0.000201	0.00312	CbGpPWpGaD
Ropivacaine—Hypotension—Epirubicin—sarcoma	0.0002	0.000585	CcSEcCtD
Ropivacaine—Confusional state—Doxorubicin—sarcoma	0.0002	0.000584	CcSEcCtD
Ropivacaine—Anaphylactic shock—Doxorubicin—sarcoma	0.000198	0.000579	CcSEcCtD
Ropivacaine—Infection—Doxorubicin—sarcoma	0.000197	0.000576	CcSEcCtD
Ropivacaine—SCN5A—L1CAM interactions—SRC—sarcoma	0.000196	0.00305	CbGpPWpGaD
Ropivacaine—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000195	0.000571	CcSEcCtD
Ropivacaine—Shock—Doxorubicin—sarcoma	0.000195	0.00057	CcSEcCtD
Ropivacaine—Thrombocytopenia—Doxorubicin—sarcoma	0.000194	0.000567	CcSEcCtD
Ropivacaine—Insomnia—Epirubicin—sarcoma	0.000194	0.000566	CcSEcCtD
Ropivacaine—Tachycardia—Doxorubicin—sarcoma	0.000193	0.000565	CcSEcCtD
Ropivacaine—SCN4A—Axon guidance—KDR—sarcoma	0.000193	0.003	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—KDR—sarcoma	0.000193	0.003	CbGpPWpGaD
Ropivacaine—Skin disorder—Doxorubicin—sarcoma	0.000192	0.000563	CcSEcCtD
Ropivacaine—Paraesthesia—Epirubicin—sarcoma	0.000192	0.000562	CcSEcCtD
Ropivacaine—Hyperhidrosis—Doxorubicin—sarcoma	0.000191	0.00056	CcSEcCtD
Ropivacaine—Dyspnoea—Epirubicin—sarcoma	0.000191	0.000558	CcSEcCtD
Ropivacaine—Somnolence—Epirubicin—sarcoma	0.00019	0.000557	CcSEcCtD
Ropivacaine—Dyspepsia—Epirubicin—sarcoma	0.000188	0.000551	CcSEcCtD
Ropivacaine—SCN1A—Axon guidance—KDR—sarcoma	0.000186	0.00289	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—KDR—sarcoma	0.000186	0.00289	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—KDR—sarcoma	0.000185	0.00288	CbGpPWpGaD
Ropivacaine—Hypotension—Doxorubicin—sarcoma	0.000185	0.000541	CcSEcCtD
Ropivacaine—SCN9A—Axon guidance—CREB1—sarcoma	0.000184	0.00286	CbGpPWpGaD
Ropivacaine—Constipation—Epirubicin—sarcoma	0.000183	0.000535	CcSEcCtD
Ropivacaine—Pain—Epirubicin—sarcoma	0.000183	0.000535	CcSEcCtD
Ropivacaine—SCN9A—Developmental Biology—FOXO1—sarcoma	0.000181	0.00282	CbGpPWpGaD
Ropivacaine—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00018	0.000528	CcSEcCtD
Ropivacaine—Insomnia—Doxorubicin—sarcoma	0.000179	0.000524	CcSEcCtD
Ropivacaine—Paraesthesia—Doxorubicin—sarcoma	0.000178	0.00052	CcSEcCtD
Ropivacaine—Dyspnoea—Doxorubicin—sarcoma	0.000177	0.000517	CcSEcCtD
Ropivacaine—Feeling abnormal—Epirubicin—sarcoma	0.000176	0.000516	CcSEcCtD
Ropivacaine—SCN3A—Axon guidance—CREB1—sarcoma	0.000176	0.00274	CbGpPWpGaD
Ropivacaine—Somnolence—Doxorubicin—sarcoma	0.000176	0.000515	CcSEcCtD
Ropivacaine—Gastrointestinal pain—Epirubicin—sarcoma	0.000175	0.000512	CcSEcCtD
Ropivacaine—Dyspepsia—Doxorubicin—sarcoma	0.000174	0.00051	CcSEcCtD
Ropivacaine—SCN3A—Developmental Biology—FOXO1—sarcoma	0.000173	0.0027	CbGpPWpGaD
Ropivacaine—SCN5A—L1CAM interactions—EGFR—sarcoma	0.000172	0.00267	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—MMP2—sarcoma	0.000171	0.00267	CbGpPWpGaD
Ropivacaine—Urticaria—Epirubicin—sarcoma	0.00017	0.000497	CcSEcCtD
Ropivacaine—Pain—Doxorubicin—sarcoma	0.000169	0.000495	CcSEcCtD
Ropivacaine—Constipation—Doxorubicin—sarcoma	0.000169	0.000495	CcSEcCtD
Ropivacaine—SCN4A—Axon guidance—CREB1—sarcoma	0.000169	0.00263	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—CREB1—sarcoma	0.000169	0.00263	CbGpPWpGaD
Ropivacaine—Body temperature increased—Epirubicin—sarcoma	0.000169	0.000495	CcSEcCtD
Ropivacaine—Abdominal pain—Epirubicin—sarcoma	0.000169	0.000495	CcSEcCtD
Ropivacaine—SCN2A—Developmental Biology—FOXO1—sarcoma	0.000167	0.00259	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—FOXO1—sarcoma	0.000167	0.00259	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—MMP2—sarcoma	0.000164	0.00255	CbGpPWpGaD
Ropivacaine—Feeling abnormal—Doxorubicin—sarcoma	0.000163	0.000477	CcSEcCtD
Ropivacaine—SCN10A—Axon guidance—CREB1—sarcoma	0.000163	0.00254	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—CREB1—sarcoma	0.000163	0.00254	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—PTPRC—sarcoma	0.000163	0.00253	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—CREB1—sarcoma	0.000163	0.00253	CbGpPWpGaD
Ropivacaine—Gastrointestinal pain—Doxorubicin—sarcoma	0.000162	0.000474	CcSEcCtD
Ropivacaine—SCN1A—Developmental Biology—FOXO1—sarcoma	0.000161	0.0025	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—FOXO1—sarcoma	0.000161	0.0025	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—PLCG1—sarcoma	0.000159	0.00247	CbGpPWpGaD
Ropivacaine—Hypersensitivity—Epirubicin—sarcoma	0.000158	0.000461	CcSEcCtD
Ropivacaine—SCN2A—Axon guidance—MMP2—sarcoma	0.000158	0.00245	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—MMP2—sarcoma	0.000158	0.00245	CbGpPWpGaD
Ropivacaine—Urticaria—Doxorubicin—sarcoma	0.000157	0.00046	CcSEcCtD
Ropivacaine—Abdominal pain—Doxorubicin—sarcoma	0.000157	0.000458	CcSEcCtD
Ropivacaine—Body temperature increased—Doxorubicin—sarcoma	0.000157	0.000458	CcSEcCtD
Ropivacaine—Asthenia—Epirubicin—sarcoma	0.000154	0.000449	CcSEcCtD
Ropivacaine—SCN1A—Axon guidance—MMP2—sarcoma	0.000152	0.00236	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—MMP2—sarcoma	0.000152	0.00236	CbGpPWpGaD
Ropivacaine—Pruritus—Epirubicin—sarcoma	0.000151	0.000443	CcSEcCtD
Ropivacaine—SCN8A—Developmental Biology—MMP2—sarcoma	0.000151	0.00235	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—KDR—sarcoma	0.00015	0.00233	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—JUN—sarcoma	0.000148	0.0023	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000147	0.00229	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—SRC—sarcoma	0.000147	0.00228	CbGpPWpGaD
Ropivacaine—Diarrhoea—Epirubicin—sarcoma	0.000146	0.000428	CcSEcCtD
Ropivacaine—Hypersensitivity—Doxorubicin—sarcoma	0.000146	0.000427	CcSEcCtD
Ropivacaine—SCN3A—Developmental Biology—KDR—sarcoma	0.000143	0.00223	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—VEGFA—sarcoma	0.000143	0.00223	CbGpPWpGaD
Ropivacaine—Asthenia—Doxorubicin—sarcoma	0.000142	0.000416	CcSEcCtD
Ropivacaine—Dizziness—Epirubicin—sarcoma	0.000142	0.000414	CcSEcCtD
Ropivacaine—SCN8A—Axon guidance—NRAS—sarcoma	0.000141	0.0022	CbGpPWpGaD
Ropivacaine—Pruritus—Doxorubicin—sarcoma	0.00014	0.00041	CcSEcCtD
Ropivacaine—SCN2A—Developmental Biology—KDR—sarcoma	0.000138	0.00214	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—KDR—sarcoma	0.000138	0.00214	CbGpPWpGaD
Ropivacaine—Vomiting—Epirubicin—sarcoma	0.000136	0.000398	CcSEcCtD
Ropivacaine—Diarrhoea—Doxorubicin—sarcoma	0.000136	0.000396	CcSEcCtD
Ropivacaine—Rash—Epirubicin—sarcoma	0.000135	0.000395	CcSEcCtD
Ropivacaine—Dermatitis—Epirubicin—sarcoma	0.000135	0.000394	CcSEcCtD
Ropivacaine—Headache—Epirubicin—sarcoma	0.000134	0.000392	CcSEcCtD
Ropivacaine—SCN1A—Developmental Biology—KDR—sarcoma	0.000133	0.00207	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—KDR—sarcoma	0.000133	0.00207	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—CREB1—sarcoma	0.000131	0.00204	CbGpPWpGaD
Ropivacaine—Dizziness—Doxorubicin—sarcoma	0.000131	0.000383	CcSEcCtD
Ropivacaine—SCN5A—Axon guidance—KDR—sarcoma	0.000131	0.00203	CbGpPWpGaD
Ropivacaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000129	0.00201	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—EGFR—sarcoma	0.000129	0.002	CbGpPWpGaD
Ropivacaine—Nausea—Epirubicin—sarcoma	0.000127	0.000372	CcSEcCtD
Ropivacaine—Vomiting—Doxorubicin—sarcoma	0.000126	0.000368	CcSEcCtD
Ropivacaine—SCN3A—Developmental Biology—CREB1—sarcoma	0.000126	0.00196	CbGpPWpGaD
Ropivacaine—Rash—Doxorubicin—sarcoma	0.000125	0.000365	CcSEcCtD
Ropivacaine—Dermatitis—Doxorubicin—sarcoma	0.000125	0.000365	CcSEcCtD
Ropivacaine—Headache—Doxorubicin—sarcoma	0.000124	0.000363	CcSEcCtD
Ropivacaine—SCN9A—Developmental Biology—MMP2—sarcoma	0.000122	0.0019	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—KRAS—sarcoma	0.000122	0.00189	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—CREB1—sarcoma	0.000121	0.00188	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—CREB1—sarcoma	0.000121	0.00188	CbGpPWpGaD
Ropivacaine—CYP1A2—Tryptophan metabolism—MDM2—sarcoma	0.000119	0.00186	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—SRC—sarcoma	0.000119	0.00185	CbGpPWpGaD
Ropivacaine—Nausea—Doxorubicin—sarcoma	0.000118	0.000344	CcSEcCtD
Ropivacaine—SCN3A—Developmental Biology—MMP2—sarcoma	0.000117	0.00182	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—CREB1—sarcoma	0.000116	0.00181	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—CREB1—sarcoma	0.000116	0.00181	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—CTNNB1—sarcoma	0.000116	0.0018	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—VEGFA—sarcoma	0.000116	0.0018	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—CREB1—sarcoma	0.000115	0.00178	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—NRAS—sarcoma	0.000114	0.00178	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—SRC—sarcoma	0.000114	0.00177	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—FOXO1—sarcoma	0.000113	0.00176	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—MMP2—sarcoma	0.000112	0.00175	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—MMP2—sarcoma	0.000112	0.00175	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—VEGFA—sarcoma	0.000111	0.00172	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—NRAS—sarcoma	0.000109	0.0017	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—SRC—sarcoma	0.000109	0.0017	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—SRC—sarcoma	0.000109	0.0017	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—MMP2—sarcoma	0.000108	0.00169	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—MMP2—sarcoma	0.000108	0.00169	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—MMP2—sarcoma	0.000107	0.00166	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	0.000107	0.00166	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—VEGFA—sarcoma	0.000106	0.00165	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—VEGFA—sarcoma	0.000106	0.00165	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—SRC—sarcoma	0.000105	0.00164	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—SRC—sarcoma	0.000105	0.00164	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—NRAS—sarcoma	0.000105	0.00163	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—NRAS—sarcoma	0.000105	0.00163	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—SRC—sarcoma	0.000105	0.00163	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—EGFR—sarcoma	0.000104	0.00162	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	0.000104	0.00161	CbGpPWpGaD
Ropivacaine—SCN8A—Axon guidance—HRAS—sarcoma	0.000103	0.00161	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—VEGFA—sarcoma	0.000103	0.00159	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—VEGFA—sarcoma	0.000103	0.00159	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—VEGFA—sarcoma	0.000102	0.00159	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—NRAS—sarcoma	0.000101	0.00158	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—NRAS—sarcoma	0.000101	0.00158	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—NRAS—sarcoma	0.000101	0.00157	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—EGFR—sarcoma	9.96e-05	0.00155	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—KRAS—sarcoma	9.84e-05	0.00153	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—EGFR—sarcoma	9.57e-05	0.00149	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—EGFR—sarcoma	9.57e-05	0.00149	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—KRAS—sarcoma	9.41e-05	0.00146	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—CTNNB1—sarcoma	9.38e-05	0.00146	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—KDR—sarcoma	9.34e-05	0.00145	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	9.31e-05	0.00145	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—sarcoma	9.31e-05	0.00145	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—EGFR—sarcoma	9.23e-05	0.00144	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—EGFR—sarcoma	9.23e-05	0.00144	CbGpPWpGaD
Ropivacaine—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	9.21e-05	0.00143	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—EGFR—sarcoma	9.19e-05	0.00143	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	9.07e-05	0.00141	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—KRAS—sarcoma	9.04e-05	0.00141	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—KRAS—sarcoma	9.04e-05	0.00141	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—CTNNB1—sarcoma	8.97e-05	0.0014	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—sarcoma	8.95e-05	0.00139	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—KRAS—sarcoma	8.72e-05	0.00136	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—KRAS—sarcoma	8.72e-05	0.00136	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—KRAS—sarcoma	8.68e-05	0.00135	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—CTNNB1—sarcoma	8.62e-05	0.00134	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—CTNNB1—sarcoma	8.62e-05	0.00134	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—SRC—sarcoma	8.48e-05	0.00132	CbGpPWpGaD
Ropivacaine—SCN9A—Axon guidance—HRAS—sarcoma	8.36e-05	0.0013	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—sarcoma	8.34e-05	0.0013	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—CTNNB1—sarcoma	8.31e-05	0.00129	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—CTNNB1—sarcoma	8.31e-05	0.00129	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—VEGFA—sarcoma	8.26e-05	0.00128	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—CREB1—sarcoma	8.19e-05	0.00127	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	8.16e-05	0.00127	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—sarcoma	8.16e-05	0.00127	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—NRAS—sarcoma	8.16e-05	0.00127	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—SRC—sarcoma	8.11e-05	0.00126	CbGpPWpGaD
Ropivacaine—SCN3A—Axon guidance—HRAS—sarcoma	8e-05	0.00124	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—VEGFA—sarcoma	7.9e-05	0.00123	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—NRAS—sarcoma	7.8e-05	0.00121	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—SRC—sarcoma	7.79e-05	0.00121	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—SRC—sarcoma	7.79e-05	0.00121	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—sarcoma	7.71e-05	0.0012	CbGpPWpGaD
Ropivacaine—SCN2A—Axon guidance—HRAS—sarcoma	7.68e-05	0.0012	CbGpPWpGaD
Ropivacaine—SCN4A—Axon guidance—HRAS—sarcoma	7.68e-05	0.0012	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—MMP2—sarcoma	7.62e-05	0.00119	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—VEGFA—sarcoma	7.59e-05	0.00118	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—VEGFA—sarcoma	7.59e-05	0.00118	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—SRC—sarcoma	7.51e-05	0.00117	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—SRC—sarcoma	7.51e-05	0.00117	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—NRAS—sarcoma	7.5e-05	0.00117	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—NRAS—sarcoma	7.5e-05	0.00117	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—EGFR—sarcoma	7.43e-05	0.00116	CbGpPWpGaD
Ropivacaine—SCN1A—Axon guidance—HRAS—sarcoma	7.41e-05	0.00115	CbGpPWpGaD
Ropivacaine—SCN10A—Axon guidance—HRAS—sarcoma	7.41e-05	0.00115	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—SRC—sarcoma	7.4e-05	0.00115	CbGpPWpGaD
Ropivacaine—SCN8A—Developmental Biology—HRAS—sarcoma	7.38e-05	0.00115	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—VEGFA—sarcoma	7.32e-05	0.00114	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—VEGFA—sarcoma	7.32e-05	0.00114	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—NRAS—sarcoma	7.23e-05	0.00112	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—NRAS—sarcoma	7.23e-05	0.00112	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—VEGFA—sarcoma	7.21e-05	0.00112	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—NRAS—sarcoma	7.12e-05	0.00111	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—EGFR—sarcoma	7.11e-05	0.00111	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—KRAS—sarcoma	7.02e-05	0.00109	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—EGFR—sarcoma	6.83e-05	0.00106	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—EGFR—sarcoma	6.83e-05	0.00106	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—KRAS—sarcoma	6.71e-05	0.00104	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—EGFR—sarcoma	6.59e-05	0.00102	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—EGFR—sarcoma	6.59e-05	0.00102	CbGpPWpGaD
Ropivacaine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	6.55e-05	0.00102	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—EGFR—sarcoma	6.49e-05	0.00101	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—KRAS—sarcoma	6.45e-05	0.001	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—KRAS—sarcoma	6.45e-05	0.001	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—KRAS—sarcoma	6.22e-05	0.000967	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—KRAS—sarcoma	6.22e-05	0.000967	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—KRAS—sarcoma	6.13e-05	0.000953	CbGpPWpGaD
Ropivacaine—SCN9A—Developmental Biology—HRAS—sarcoma	5.97e-05	0.000928	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—CTNNB1—sarcoma	5.84e-05	0.000909	CbGpPWpGaD
Ropivacaine—SCN3A—Developmental Biology—HRAS—sarcoma	5.71e-05	0.000888	CbGpPWpGaD
Ropivacaine—SCN2A—Developmental Biology—HRAS—sarcoma	5.48e-05	0.000853	CbGpPWpGaD
Ropivacaine—SCN4A—Developmental Biology—HRAS—sarcoma	5.48e-05	0.000853	CbGpPWpGaD
Ropivacaine—SCN1A—Developmental Biology—HRAS—sarcoma	5.29e-05	0.000822	CbGpPWpGaD
Ropivacaine—SCN10A—Developmental Biology—HRAS—sarcoma	5.29e-05	0.000822	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—SRC—sarcoma	5.28e-05	0.000821	CbGpPWpGaD
Ropivacaine—SCN5A—Axon guidance—HRAS—sarcoma	5.21e-05	0.00081	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—VEGFA—sarcoma	5.14e-05	0.0008	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—NRAS—sarcoma	5.08e-05	0.00079	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—EGFR—sarcoma	4.63e-05	0.00072	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—KRAS—sarcoma	4.37e-05	0.00068	CbGpPWpGaD
Ropivacaine—SCN5A—Developmental Biology—HRAS—sarcoma	3.72e-05	0.000578	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—ENO2—sarcoma	3.34e-05	0.00052	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—HBA1—sarcoma	3.32e-05	0.000516	CbGpPWpGaD
Ropivacaine—CYP2B6—Metabolism—PLCG1—sarcoma	2.84e-05	0.000441	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—ENO2—sarcoma	2.32e-05	0.000361	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—HBA1—sarcoma	2.31e-05	0.000359	CbGpPWpGaD
Ropivacaine—CYP2D6—Metabolism—PLCG1—sarcoma	1.97e-05	0.000306	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—ENO2—sarcoma	1.97e-05	0.000306	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—HBA1—sarcoma	1.96e-05	0.000304	CbGpPWpGaD
Ropivacaine—CYP1A2—Metabolism—PLCG1—sarcoma	1.67e-05	0.00026	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—ENO2—sarcoma	1.52e-05	0.000236	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—HBA1—sarcoma	1.51e-05	0.000235	CbGpPWpGaD
Ropivacaine—CYP3A4—Metabolism—PLCG1—sarcoma	1.29e-05	0.0002	CbGpPWpGaD
